BioCentury
ARTICLE | Clinical News

Dusquetide regulatory update

December 14, 2016 11:05 PM UTC

The U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA) granted promising innovative medicine (PIM) designation to dusquetide from Soligenix to treat severe oral mucositis in head and ne...

BCIQ Company Profiles

Soligenix Inc.

BCIQ Target Profiles

Sequestosome 1 (SQSTM1) (p62)